Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Operating Expenses (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Operating Expenses data on record, last reported at $11.1 million in Q2 2025.

  • For Q2 2025, Operating Expenses fell 26.71% year-over-year to $11.1 million; the TTM value through May 2025 reached $52.2 million, up 2.95%, while the annual FY2025 figure was $50.6 million, 0.27% changed from the prior year.
  • Operating Expenses reached $11.1 million in Q2 2025 per LFCR's latest filing, roughly flat from $11.1 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $17.0 million in Q3 2024 and bottomed at -$4.0 million in Q2 2021.
  • Average Operating Expenses over 5 years is $10.9 million, with a median of $11.4 million recorded in 2023.
  • Peak YoY movement for Operating Expenses: crashed 64.74% in 2021, then skyrocketed 320.47% in 2023.
  • A 5-year view of Operating Expenses shows it stood at $7.3 million in 2021, then surged by 50.76% to $11.0 million in 2022, then increased by 3.71% to $11.4 million in 2023, then rose by 14.01% to $13.0 million in 2024, then fell by 15.03% to $11.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Expenses were $11.1 million in Q2 2025, $11.1 million in Q1 2025, and $13.0 million in Q4 2024.